Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01498718
What this trial is testing

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 131
Early research (Phase 1)Study completedNCT01333462
What this trial is testing

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Who this might be right for
Healthy Adult Volunteers
NanoBio Corporation 199
Post-approval studies (Phase 4)Study completedNCT01111162
What this trial is testing

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University of Pennsylvania 120
Post-approval studies (Phase 4)Study completedNCT01356342
What this trial is testing

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old

Who this might be right for
Influenza
Adimmune Corporation 181
Post-approval studies (Phase 4)Study completedNCT00138294
What this trial is testing

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program

Who this might be right for
Influenza
Baylor College of Medicine 29,255
Large-scale testing (Phase 3)Study completedNCT00630331
What this trial is testing

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 11,404
Large-scale testing (Phase 3)Study completedNCT00971542
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 778
Testing effectiveness (Phase 2)Study completedNCT00258934
What this trial is testing

Immunogenicity Study of the Influenza Vaccine in Adults

Who this might be right for
Orthomyxoviridae InfectionsInfluenza
Sanofi Pasteur, a Sanofi Company 978
Large-scale testing (Phase 3)Study completedNCT00665509
What this trial is testing

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.

Who this might be right for
Influenza
Solvay Biologicals 120
Large-scale testing (Phase 3)WithdrawnNCT01810731
What this trial is testing

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Who this might be right for
Influenza, HumanHIVMalaria+2 more
Centers for Disease Control and Prevention
Testing effectiveness (Phase 2)Study completedNCT00388583
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 817
Large-scale testing (Phase 3)Study completedNCT05869201
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Who this might be right for
InfluenzaInfluenza, HumanInfluenza Viral Infections+2 more
St. Petersburg Research Institute of Vaccines and Sera 450
Testing effectiveness (Phase 2)Study completedNCT00954798
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 450
Early research (Phase 1)Study completedNCT00356798
What this trial is testing

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT00519064
What this trial is testing

Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

Who this might be right for
Influenza Disease
Novartis Vaccines 361
Large-scale testing (Phase 3)Study completedNCT00554333
What this trial is testing

Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 795
Not applicableStudy completedNCT01023711
What this trial is testing

Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus

Who this might be right for
Influenza
University of Rochester 107
Large-scale testing (Phase 3)Study completedNCT00945841
What this trial is testing

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

Who this might be right for
Seasonal Influenza
Novartis 126
Post-approval studies (Phase 4)Study completedNCT01691326
What this trial is testing

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 60
Early research (Phase 1)Study completedNCT03816878
What this trial is testing

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 32
Next Page